Time-to-Event Outcomes of Blinatumomab Versus Chemotherapy in First-Relapse Pediatric and Adolescent/Young Adult B-Cell Acute Lymphoblastic Leukemia: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis of Randomized Controlled Trials

Blincyto (blinatumomab) - Amgen

https://www.sciencedirect.com/science/article/abs/pii/S2152265026017222

Abhinav V Paramkusam MD 1; Sahithi MC Paramkusam MBBS 2; Mehak Dang MD 3; Sravani Bhavanam MD 4; Aashray Raj MD 5; Sameer Kumar Majety MBBS 6; Fahad Alabbas MD 7

Sep 1, 2026